Insights on Clinical Trials
-
ESMO Congress 2025: Highlights From Berlin
11/24/2025
Turn the insights from this year’s ESMO into action by partnering to accelerate innovation through smarter trial design, stronger biomarker planning, and truly global collaboration.
-
The Evolving Role Of Healthy Participants In Early Immuno-Oncology Trials
11/21/2025
Explore how leveraging healthy participants, advanced immune-challenge models, and high-dimensional biomarker analyses can transform early immuno-oncology development.
-
7 Patient Recruitment Best Practices Used By Leading Research Studies
11/17/2025
Effective patient recruitment starts with trust. Leading trials build lasting relationships and prioritize respect, simplicity, and community engagement to overcome enrollment challenges.
-
Ease Is How Good Work Happens
11/17/2025
Clinical research teams thrive in the Flow State, where systems align, data connects, and work becomes purposeful, not painful. Ease is clarity, not complexity.
-
The True Cost Of Tool Sprawl
11/17/2025
Tool sprawl in clinical trials creates hidden inefficiencies, fractured collaboration, and delayed insights. Unified systems restore flow, clarity, and control across research teams and functions.
-
Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer
11/17/2025
Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.
-
Early Phase Oncology Site Network: Benefits Of A Personal Touch
11/17/2025
Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.
-
The Growing Complexity Of Conducting Oncology Trials
11/17/2025
As diversity plans and multi-regional considerations become core to trial design, early-phase oncology programs must navigate a landscape that offers unprecedented opportunity.
-
Investor Relations, Clinical Operations, And The Future Of Biotech Financing
11/17/2025
Discover how integrating clinical execution with investor strategy can strengthen your position in a tougher capital landscape and accelerate your path to market.
-
Lost In Translation: Turning Multi-Omic Chaos Into Clinical Clarity
11/17/2025
Uncover how this integrated, science-focused approach helps sponsors navigate biological complexity, streamline timelines, and make data-driven decisions across a collection of therapy programs.